<p>Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.</p>

Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.

Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Medicine

Health & Fitness

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Share Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

Sign up to save your podcasts

Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

More shows like The Uromigos

EconTalk

WSJ What’s News

Freakonomics Radio

Fareed Zakaria GPS

TED Radio Hour

Hidden Brain

Worklife with Adam Grant

The Readout Loud

Plenary Session

GU Cast | Urology Podcast

People I (Mostly) Admire

ReThinking

All the Hacks with Chris Hutchins

Two Onc Docs